Skip to main content

Table 3 Demographics of individuals with chronic HBV and acute HIV-1 co-infection

From: Hepatitis B virus (HBV)-specific T-cell responses to recombinant HBV core protein in patients with normal liver function and co-infected with chronic HBV and human immunodeficiency virus 1 (HIV-1)

   

v1

  

v2

  

v3

 

Patient

HBeAg

HBV DNAa

HIV RNAa

CD4 count

HBV DNAa

HIV RNAa

CD4 count

HBV DNAa

HIV RNAa

CD4 count

AHI01

pos

8.45

5.66

376

7.38

5.66

212

3.52b

<ldlb

376

AHI02

pos

6.54

4.55

533

7.43

4

298

7.76

ND

405

AHI03

neg

<ldl

3.89

213

<ldl

ND

192

<ldl

ND

189

AHI04

pos

7.71

3.75

345

8.2

4.47

275

8.4

ND

342

AHI05

pos

9.04

5.72

363

8.32

ND

292

7.14

ND

363

AHI06

neg

<ldl

2.23

361

<ldl

ND

345

<ldl

ND

221

AHI07

pos

8.14

6.1

412

8.45

ND

329

7.54

ND

293

AHI08

neg

<ldl

4.92

308

<ldl

4.67

365

<ldl

ND

395

AHI09

neg

<ldl

3.39

922

<ldl

3.3

862

<ldl

ND

692

AHI10

neg

<ldl

6.31

380

<ldl

ND

464

<ldl

ND

243

AHI11

neg

<ldl

5.62

221

<ldl

ND

445

<ldl

ND

445

  1. pos HBeAg positive, neg HBeAg negative; v1, 2, 3: followed up on 3rd, 12th, 24th month post acute HIV-1 infection; alog10; bHAART with AZT/3TC/LPVr; ldl lower limit of detection, ND not done.